Publication | Closed Access

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPathologyImmune Checkpoint InhibitorPrognostic SignificanceImmunotherapyOncologyCaspase-3 Immunohistochemical Expression